The article ‘How partnerships are driving new treatments for tuberculosis’ has just been published on World…
Andrea GarciaSeptember 21, 2022
More than 120 representatives of ERA4TB partners are meeting face to face with the occasion…
IT SynapseJune 17, 2022
ERA4TB announced on the 4th Consortium Meeting that CIM – Sant Pau (IIB Sant Pau)…
IT SynapseFebruary 1, 2022
Dr Gilla Kaplan, Ph.D. Former Director of the Global Health Program, Tuberculosis, at the Bill…
IT SynapseFebruary 1, 2022
On the 27th and 28th of January 2022, Consortium members gathered virtually for two days…
IT SynapseJanuary 31, 2022
The ERA4TB 4th Consortium Meeting is taking place next 27th -28th January 2022 as a…
Inari SoininenDecember 3, 2021
TBAJ-587-CL-001 is the first Phase 1 trial in humans conducted by TB Alliance through the…
Inari SoininenNovember 26, 2021
The third ERA4TB Consortium Meeting took place last June 9th and 10th with the participation…
Inari SoininenJune 15, 2021
An estimated 1.4 million fewer people received care for tuberculosis (TB) in 2020 than in…
Inari SoininenMarch 26, 2021
